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Abstract 
Subjective colour spaces were reconstructed for persons occupationally exposed to mercury 
(Hg) and patients with diabetes mellitus type 2 (DM-2), two groups at risk for acquired colour-
vision deficiency, and compared with healthy normal trichromats. Judgments of colour 
dissimilarity were collected with the method of triads, applied to a composite assortment of 
colour samples. These were drawn from two widely-used colour arrangement tests – ten hues 
from the Farnsworth D-15 test and five from the Lanthony Desaturated D-15d test, ensuring 
that the assortment sampled two levels of lightness and saturation. The data were analysed with 
Maximum-Likelihood multidimensional scaling (MDS) and within a novel Individual-
Differences MDS model to estimate subject-specific parameters. The MDS solutions for the 
two clinical groups showed a compression along a Blue-Yellow axis, limited however to 
desaturated hues. This result was confirmed by the individual-differences model. In addition, 
the clinical groups were found to place significantly higher weights on the lightness differences 
between stimuli, conceivably to compensate for their reduced chromatic discrimination. The 
specific form of colour-space distortion in the clinical groups indicated an increase in their 
thresholds for blue-yellow signals, providing insights into the nature of impairment 
mechanisms. The results have implications for stimuli and diagnostic procedures for testing 
individual differences in color vision, and for analyzing the responses. The present approach is 
sensitive to distinctive patterns of subtle colour-vision impairment underestimated by the 
conventional D-15d test. 
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Introduction 
 
The D-15 and D-15d are two widely-used tests for detecting and quantifying deficits of colour 
perception.
1,2
 Both are ‘panel tests’ in which 16 coloured samples, located by their 
specifications in colour space so as to form an incomplete circle, must be arranged into the 
correct rainbow sequence. In each case an error score measures overall loss of colour 
discrimination. These tests also qualify the nature of colour vision loss, distinguishing blue-
yellow (B/Y) and/or red-green (R/G) impairment. Their advantages include speed and 
convenience; the D-15d, in addition, is sensitive to mild forms of colour vision impairment. The 
D-15 is designed for classifying an individual within the diagnostic taxonomy of congenital 
colour vision deficits, determining the ‘polarity’ of the deficiency, i.e. B/Y or R/G, if it exceeds 
a threshold of severity. The D-15d lends itself well to assessing acquired deficits where early 
detection of a progressive impairment can be crucial, and is less clear-cut, i.e. the breakdown by 
polarity is often less clear than for congenital deficiency. For these reasons, the D-15d sees 
applications in many clinical studies 
3-5
 as well as in the area of occupational optometry, where 
deficits may be the result of work-related exposure to toxins (for a review see Ref. 6). 
From one perspective, a subject’s responses to panel tests such as the D-15 and D-15d can 
be regarded as a ranking of the pairwise dissimilarities among the colour samples, from most-
similar to the least-similar pair.
7
 A subject may approach the samples with some alternative 
procedure – sorting them into groups, for instance – and as long as the responses can be treated 
as comparisons amongst dissimilarities, they can be analysed within the same over-arching 
framework. 
Bimler and Kirkland 
8
 used the method of triads 
9
 to elicit ‘odd-one-out’ data for a 
combined set of D-15 and D-15d samples, presenting a series of triadic combinations to each 
subject who had to choose the least similar sample from each three. Most combinations require 
saturated, darker stimuli from the D-15 to be considered against desaturated, lighter ones from 
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the D-15d, so the odd-one-out choice may vary if the observer places more weight on either hue 
or lightness differences. In addition, a triad might probe similarities at the scale of barely-
discernable differences (as with the D-15d) or at a coarse, supra-threshold scale (with D-15), 
depending on its constituent samples. Analysis of the data with multidimensional scaling 
(MDS) allows a subjective colour space to be reconstructed for each individual or certain 
groups of individuals.
10
 This analysis of similarity data from the combined colour samples has 
revealed subtle differences, for example, between smoking and non-smoking groups,
11
 
monozygotic and dizygotic twins,
12
 between females and males 
8
 and between homozygous 
females and heterozygous carriers of colour vision deficiency.
13 
For clinical populations, Feitosa-Santana and her colleagues elicited odd-one-out 
responses of this form – for randomized triads of a combined D-15 and D-15d stimulus set – for 
age-matched normal controls and groups whose colour vision had potentially been impaired by 
exposure to mercury vapour
14
 or by diabetes mellitus type 2.
15
 For convenience, though without 
losing generality or statistical power, the triads in these studies did not follow a predetermined 
list, but rather were generated randomly. 
The MDS solutions for both clinical groups
14,15
 revealed distributions significantly 
different from those in the respective control groups. The clinical groups’ colour spaces tended 
to show a greater level of distortion and higher variability in the locations of stimuli along the 
B/Y axis, i.e. possible tritan-type polar deficiency with a B/Y confusion axis. 
In the present study we are interested in whether the variations between individuals – and 
between clinical and control groups – take the form of relative insensitivity along specific 
directions in colour space, since a specific loss of sensitivity can provide clues to the neural 
locus (or loci) of the visual system implicated in an acquired deficiency. As Krastel and 
Moreland (Ref. 16, p. 117) note, “…acquired tritan deficits may be subjectively quite 
unobtrusive and well tolerated”; that is, decreases in hue discrimination (i.e. increased 
thresholds) do not necessarily affect subjective colour experience or reach the level of 
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awareness. The method used here allows for the possibility of capturing subtle hue 
discrimination impairments by using relatively desaturated stimuli along with saturated ones. 
Thus subjects are required to consider small hue differences (close to threshold) between 
relatively similar pairs of stimuli, as well as larger, supra-threshold differences. 
In the geometrical paradigm, a polar deficiency is represented as a compression of colour 
space.
10
 Here this was tested by re-analysing the data of Feitosa-Santana et al.
14,15
 within the 
framework of individual-differences MDS. The latter imposes a single geometrical solution 
upon all the subjects, while allowing that solution to vary in a particular way (compression 
along a confusion axis) controlled by a small number of parameters, to fit it to each subject’s 
responses. A subject’s data are thereby boiled down to their values of the parameters. 
 
Acquired colour vision impairment and occupational mercury exposure 
 
Mercury, both in its elemental form (e.g. mercury vapour) and as an organic compound 
(methylmercury), is a potent neurotoxin that can cause a range of perceptual, motor and 
cognitive impairments.
17-20 
Inter alia, mercury exposure is known to affect colour vision.
21-23
 The impairment 
manifests itself, in particular, as increased colour discrimination thresholds and decreased 
chromatic contrast sensitivity.
24,25
 As Pokorny, Smith, Verriest, and Pinckers (Ref. 26, p. 309) 
note , “[a] generalized depression of optic nerve conduction characterized by peripheral 
constriction of the visual fields and optic atrophy is a clinical picture found in […] mercury 
toxicity (Minimata disease)”. In the periphery of the visual system, impairment of inner and 
outer retinal function was found, indicating damage to post-receptoral structures.
25
 Nor can 
damage to the visual cortex be excluded.
27,28
 Estimating specific loss of sensitivity, i.e. 
delineation of the confusion axes in colour space, can provide clues to the neural locus (or loci) 
affected by mercury. 
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The D-15d test revealed higher error scores in mercury exposed persons, with a higher 
frequency of blue-yellow confusion [Type III dyschromatopsia, according to Verriest’s 
classification
29
], regardless of whether they were exposed occupationally
21,23
 or via 
contaminated food.
18,19
 Employment of the Farnsworth-Munsell 100-hue test (FM-100) showed 
that mercury-contaminated subjects performed significantly worse than matched controls, but 
revealed no distinct confusion axis in colour space.
24 
When tested with the Cambridge Colour Test (CCT),
30
 subjects exposed to mercury 
revealed increased chromatic discrimination thresholds along all three confusion axes (protan, 
deutan and tritan) and non-selective enlargement of MacAdam ellipses. These findings related 
to gold miners,
24
 workers in the fluorescent-tube industry (Feitosa-Santana et al., 2008)
25,28,31
 
and dentists, exposed through dental amalgam.
32 
 
Development of colour vision impairment in diabetes mellitus type 2 
 
The sequelae of diabetes mellitus include colour vision impairment: persistent hyperglycemia 
causes retinal micro vascular changes that damage the retina (diabetic retinopathy, DR), leading 
to losses in visual acuity and contrast sensitivity, as well as in colour vision.
33
 In diabetic 
patients, elevated thresholds for cone photoreceptors have been reported and attributed to the 
concentration of circulating glucose and a reduction of the oxygen supply.
34
 Notably, 
subclinical or mild colour vision impairment may precede DR to emerge at early stages of type 
2 diabetes mellitus (DM-2), before the appearance of vascular alterations. 
Colour vision of DM-2 patients was examined in many studies using panel tests, such as 
the FM-100,
 35-37
 as well as D-15 and/or D-15d test.
15,38
 Anomaloscopy has been employed to 
estimate Rayleigh and Moreland matches for the two perceptual systems, R/G and B/Y 
respectively.
39
 Crucially, the extrapolation from anomaloscope matching range to colour 
impairment is far from direct. More recently, the CCT has been used to estimate colour 
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discrimination thresholds along the protan, deutan and tritan confusion lines.
38 
An effect on the B/Y, or tritan system, is repeatedly found in DM-2 patients. In patients 
without DR, predominantly tritan losses were diagnosed,
33
 however diffuse losses were 
reported as well.
40,41
 In DM-2 patients who had developed DR, losses in the B/Y system were 
found to increase with severity of DR.
33,42-44 
Feitosa-Santana et al. assessed colour vision impairment in DM-2 patients without diabetic 
retinopathy.
15,38
 The present study re-examines those data. 
 
Method 
 
Subjects 
 
All patients and controls underwent an ophthalmological examination, with the following 
inclusion criteria: best corrected Snellen visual acuity (VA) 20/30 or better; absence of 
retinopathy, ocular disease and posterior sub capsular cataract; maximum of grade 1 for cortical 
opacity (C1), nuclear colour (NC1) and nuclear opalescence (NO1) following the lens opacity 
classification system III (LOCS III). Clinical histories were collected to exclude alcoholism, 
smoking and systemic diseases that could affect the visual system. Observers with congenital 
colour deficiency were excluded using the D-15 test. 
The mercury (Hg)-exposed group included 22 subjects who had been exposed to Hg 
vapour for at least five years working in fluorescent lamp industries. All had been discharged 
from work at least one year earlier and placed on disability retirement due to medical diagnosis 
of Hg intoxication based on clinical and laboratory examination. They had been referred by the 
Occupational Health Service of the Oscar Freire Institute of the University of São Paulo 
(Brazil). Table 1 in Ref. 14 tabulates details for 18 of these subjects (13 males), aged 42.1  6.5 
years; the four additional subjects had similar demographic characteristics. 
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The DM-2 group consisted of 32 patients (18 males), aged 30 to 76 years (50.5  10.7), 
with disease duration from 0.5 to 27 years (9  8.6). The absence of retinopathy was verified by 
fundoscopy (in 100% of the eyes) and by fundus photography and fluorescein angiography 
(62% of the eyes were examined; 100% of these lacked any sign of retinopathy).
31,38 
Twenty-three observers (15 males), aged 35 to 80 years (51  12), served as controls. An 
age-matched subset of 18 of these observers were used as controls in Ref. 14 (Table 2), and 20 
as controls in Ref. 15; age-matching was less rigid in the present analysis. 
 
Procedure 
 
The D-15 and D-15d tests each consist of 16 colour samples (plastic caps holding 12-mm 
circles of pigment on paper), occupying an incomplete circle in colour space. In Munsell 
denotation, the D-15 caps have Value = 5 and Chroma = 4;
1 
the D-15d caps have the same hues 
but are lighter, with Value = 8, and less saturated, Chroma = 2.
2
 Because of the lower saturation 
of the D-15d stimuli, differences between them are closer to threshold.
3,4,45
 A composite 
assortment of 15 caps was created from the D-15 series by replacing caps No. 3, 6, 9, 12 and 15 
with their counterparts from the D-15d and excluding the “pilot” caps, which were anchored to 
the test trays. This assortment was shuffled into five randomized groups of three. The subject 
viewed each triad in turn and chose the most dissimilar cap of the three (the odd-one-out). 
No time limit was set. This procedure was repeated 12 times. The subject also judged five 
random triads created by shuffling the D-15 caps and five from the D-15d caps, providing a 
total of 70 triad judgments.
11,12
 At the beginning of the session, the D-15 and D-15d caps were 
both used in the traditional way: the subject arranged them in a colour sequence, starting with 
the pilot cap and following each cap with the cap most similar to it. 
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The procedure was conducted monocularly. Control subjects were tested in only one eye. 
Subjects from the clinical groups repeated the procedure for both eyes (with random choice of 
testing left or right eye first) since acquired colour discrimination loss is not necessarily 
symmetrical.
29
 Thus the 15 caps comprising the composite assortment were viewed 13 times by 
each control subject and 26 times by each clinical subject. The ten D-15d and five D-15 caps 
were viewed once by each control subject (in the five desaturated-only and five saturated-only 
triads respectively) and twice by each clinical subject. 
Illumination of 500 lux was provided by two fluorescent lamps (Sylvania Octron 6500 K 
FO32W / 65K), with Coordinated Color Temperature = 6500K, Color Rendering Index = 75). 
 
MDS analysis 
 
We set out to reconstruct multidimensional colour spaces in which points represent the hues and 
are located so that the spatial distance between any two points reflects the perceived 
dissimilarity between that pair of hues. Each triad of caps corresponds to a triangle of points, in 
which the apex should be the hue chosen as odd-one-out. 
For an initial exploratory analysis, the subjects’ data were combined within each group 
and analysed with the existing ‘MTRIAD’ software11-14 to obtain three separate solutions, i.e. 
consensus colour spaces for the controls, Hg and DM-2 groups. MTRIAD applies a maximum-
likelihood algorithm, similar to the MAXSCAL algorithm for dissimilarity comparisons.
46
 A 
Likelihood function LL(X) quantifies the agreement between the solution and the individual 
triads comprising the data. LL(X) is maximised in an iterative process that begins with initial 
estimates of the coordinates locating 30 points in the space, then adjusts them to progressively 
converge on a solution in which the inter-point distances are more likely than any other 
combination of distances to have produced the observed odd-one-out decisions. Appendix A 
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provides more detail (see also Ref. 7). A similar logic, in one dimension, features in Maximum 
likelihood difference scaling.
47,48 
MTRIAD is available from the corresponding author. 
To foreshadow the Results: constrained three-dimensional solutions were chosen for each 
group since we found that three dimensions provided a substantial improvement in Likelihood 
compared to two dimensions, whereas the addition of a fourth dimension brought little further 
improvement. As expected, the first two dimensions lent themselves for interpretation as 
perceptual colour-opponent systems, R/G and B/Y. The third dimension was interpretable as 
variation of lightness (Value) among stimuli. 
Each solution can be written as a 30-by-3 matrix X, where the i-th row contains the 
coordinates {xi1, xi2, xi3} that locate that hue along the three dimensions of the colour space. 
Sometimes a MDS solution can be rotated to bring its axes into correspondence with the 
familiar colour dimensions, so that the contribution from two points’ separation along the first 
axis (i.e. xi1-xj1) corresponds to their displacement along (e.g.) the R/G dimension, and so on. 
This cannot be assumed in advance, however. 
When the three group exploratory solutions were compared (as detailed below), they gave 
the impression that subjects in the clinical groups tended to be less sensitive to blue-yellow 
colour differences, resulting in a compression of colour space along the corresponding axis, but 
only for the desaturated hues. This impression was quantified in a confirmatory stage, 
analysing each subject’s data in isolation. 
 
Confirmatory analysis 
 
Our previous research with the same method and hues and a larger pool of subjects (Ref. 12, 
Figure 1) provided X0, a ‘standard’ matrix of coordinates in a default, consensus colour space. 
In the present analysis, X0 was distorted (compressed) to produce individual colour spaces Xm 
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tailored to the m-th subject’s responses. This entailed two subject-specific parameters, wm2 and 
wm3 (or two parameters for each eye of subjects in the clinical populations). 
For each individual space Xm, wm2 is the weight or salience of the second dimension 
relative to the first dimension: xmi2 = wm2 x0i2 (where the index i labels the hues). Because X0 
has been rotated so that its second dimension corresponds to the tritan confusion axis, values of 
wm2 < 1 indicate blue-yellow (tritan) deficiency, ranging in severity, with its extreme form, 
tritanopia, indicated by wm2 = 0 (i.e. subject m would see no distinction between two hues that 
differ only in stimulation to the S-cones, and are separated only along the B/Y axis). 
Conversely, wm2 > 1 results if the m-th subject is relatively insensitive to red-green differences, 
with larger values indicating increasingly severe R/G deficiency. 
So far we follow a number of precedents. However, in a departure from that research 
tradition, the model tested here only imposes wm2 upon the locations of the desaturated hues –  
with the saturated hues retaining their default values of x0i2 – based on the evidence that any 
acquired colour deficiency disproportionately affects discrimination of desaturated colours. 
Recall that the desaturated D-15d caps differ from those of the D-15 series in lightness 
(Value). Combined with the range of hues, the lightness differences require a third dimension to 
accommodate them within the solutions from the exploratory analyses. X0 is likewise three-
dimensional, with the D-15 and D-15d points occupying two parallel planes. Notably, subjects 
can vary in the weight they place on lightness differences in their dissimilarity perceptions.
49,50
 
The parameter wm3 accommodates these variations through the equation xmi3 = wm3 x0i3. 
The two parameters, wm2 and wm3, were adjusted systematically, summing LL(Xm) for 
each combination, to find the particular values that maximized the fit between Xm and the m-th 
data set. The distributions of wm2 and wm3 within each subject group can be compared among 
the control and two clinical groups, and any differences tested for significance. 
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Results 
 
MDS analysis 
 
We examined two-dimensional and three-dimensional MDS solutions for each subject group. In 
each case the third dimension was interpretable (after rotation) as lightness or Value, arranging 
the points in two roughly parallel planes in space. To reduce the degrees of freedom and for 
ease of display, we also examined constrained solutions in which the darker D-15 caps (V = 5) 
all shared a single coordinate on the third dimension (i.e. the mean around which they cluster), 
and the lighter D-15d caps (V = 8) all shared a second common coordinate. 
The log-likelihoods for 2D solutions for the controls, Hg and DM-2 groups were LL(X) = 
-848, -2420 and -3650 respectively. For constrained 3D solutions with one additional degree of 
freedom the corresponding values were -794, -2070 and -3380, the improvements being ΔLL = 
54, 350 and 270. According to the Likelihood Ratio Test, 2ΔLL follows a χ2 distribution, so the 
improvements are all significant (p < 0.001).
46
 Unconstrained 3D solutions (with another 26 
degrees of freedom) bring LL(X) up to -753, -1990 and -3295. Though smaller, the further 
improvements ΔLL = 41, 80 and 85 are all significant, i.e. the third-dimensional coordinates do 
depart from the two parallel planes. 
Figure 1 shows the constrained 3D solutions, labelled for convenience XC (controls), XHg 
and XDM-2. Oblique perspectives are shown in the left-hand panels. The right-hand panels show 
projections on the first two dimensions, which can be interpreted as Red-Green (D1) and Blue-
Yellow (D2) gradients. Consistently, the saturated and desaturated colours are each arranged in 
a rough horseshoe (shown by solid and dotted lines respectively), following the expected 
sequence from Purple (5P) through Red (5R), Yellow (5Y) and Green (5G) through to Blue 
(5B). The 15 stimuli comprising the ‘composite assortment’ are localised more tightly than the 
other 15, because (as noted in the Procedure) they were triangulated by appearing in 13 times as 
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many triads. The stimuli excluded from the assortment are localised in the top, middle and 
bottom panels of Figure 1 by 23, 44 and 66 triads respectively, and their confidence bounds 
would be looser. 
------------------------- 
Figure 1 about here 
------------------------- 
The constrained MDS confines the stimulus-points to two planes – separated by the third 
dimension, lightness, or Value (D3) – as shown in the left-hand panels. These planes contain 
respectively the darker/saturated stimuli (Value = 5, Chroma = 4) and the lighter/desaturated 
stimuli (Value = 8, Chroma = 2). 
The right-hand panel for control normal trichromats (XC) shows the two stimulus 
sequences spanning similar ranges of the first two dimensions. That is, corresponding 
dissimilarities among saturated and desaturated colours are seen as comparable, even though 
the former are twice as far from White as the latter in Munsell terms (Chroma = 4 vs. 2) or 
greater in CIE1931 terms (see Ref. 5, Figure 2). This is not unexpected, since in earlier results 
other groups of normal trichromats were equally willing to discount saturation 
8,11
. 
There is a crucial contrast in the two clinical population solutions, XHg and XDM-2. There, 
both sequences are spread out equally along the R/G axis but the desaturated stimuli do not 
seem to occupy as much of the B/Y axis as do the saturated stimuli. That is, the arrangement of 
desaturated stimuli is elliptical rather than circular. In addition the gap separating the 
desaturated stimuli from saturated stimuli along the lightness dimension D3 appears to be larger 
(left-hand panels). 
These visual impressions can be tested by examining the dispersal of points along each 
axis of the MDS solution (i.e. the variance of coordinates along each axis), as a fraction of total 
variance (Table 1). D1 disperses the stimuli by about the same extent in all three solutions. 
However, compared to the controls, the dispersal for the clinical groups is smaller along D2 
(Blue-Yellow), with a compensatory increase along D3 (Value). More specifically, when we 
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partition the D2 dispersal into separate contributions from the saturated and desaturated stimuli, 
the decrease in the two clinical groups is confined to the desaturated component. 
------------------------- 
Table 1 about here 
------------------------- 
Note that this kind of saturation-dependent effect does not conform to the assumptions of 
the weighted-Euclidean model of individual differences. Inter-subject variations of this form 
can be modelled within the weighted-Euclidean framework, but the resulting dimensional-
salience parameters will be a compromise between saturated and desaturated stimulus sets. 
 
Confirmatory analysis 
 
To disentangle the dissimilarity impact on saturated and desaturated colours, individual 
subjects’ responses were fitted separately for a model of individual variation suggested by 
Figure 1, in which a parameter wm2 tailors a standard colour space X0 by varying the B/Y 
contribution to inter-item dissimilarity, but only for the desaturated stimuli. A second parameter 
wm3 reflects the dissimilarity contribution from lightness differences. The distributions of the 
parameters are plotted as histograms for each group in Figure 2. Values of wm2 were lower 
across the clinical groups compared to the controls (p = 0.004), to the extent that many subjects 
appeared to be oblivious to the blueness or yellowness of desaturated stimuli. The group 
differences remained significant when comparing controls to the DM-2 group, but not to the Hg 
group separately (Table 2); the two clinical groups did not differ significantly. 
------------------------- 
Figure 2, Table 2 about here 
------------------------- 
When presented with triads that comprised one (or two) lighter/less saturated stimuli and 
two (or one) darker/saturated stimuli, the Hg and DM-2 subjects also attended more than the 
controls to lightness when choosing the odd-one-out, as reflected in higher wm3 values (Figure 
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2, bottom). The difference in the wm3 distributions was significant between the control and both 
clinical groups (Table 2), with no significant difference between the clinical groups. 
Figure 3 plots wm3 against wm2, with the three subject groups distinguished by colour. 
Points for seven representative subjects are plotted in the wm2 / wm3 ‘weight plane’ in Figure 4, 
with confidence bounds. In each case the ellipsoidal outer bound is the locus of weights where 
the Likelihood of the weighted Xm predicting the observed responses falls to 0.01 of its 
maximised value [i.e. LL(Xm) is lower by log(0.01) = -4.6], while the Likelihood at the inner 
bound is 0.05 of its maximised value [LL(Xm) is lower by -3]. 
------------------------- 
Figures 3, 4 about here 
------------------------- 
Finally, we found that likelihood was significantly lower across each of the two clinical 
groups than across the control group (Table 2). This is consistent with global difficulty in 
colour discrimination in addition to the blue-yellow deficiency apparent here. Likelihoods 
would also be lower if our model of individual differences simply was not valid for the Hg and 
DM-2 groups; i.e. these subjects’ responses could be highly discriminant, and consistent with 
colour spaces derived from X0, but through some other transformation. However, this 
interpretation is not compatible with Figure 1. 
As an afterthought we applied a more conventional Weighted Euclidean model of 
individual variation, varying the parameters wm2 and wm3, but applying the former to all stimuli 
(saturated as well as desaturated). Mean values for wm2 did not differ so much between groups: 
0.98, 0.91 and 0.90, for the controls, Hg and DM-2 respectively. The difference between wm2 
values for the controls and the combined clinical groups no longer quite reached significance (p 
= 0.063). However, mean likelihood values were lower for this model than for the desaturation-
specific model, causing us to prefer the latter. 
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Discussion 
 
Previous MDS analyses of these data
14,15
 considered each observer’s responses separately, and 
focussed on the five D15 and ten D-15d caps used in the combined assortment, omitting the 
other 15 caps that each observer only sorted once. Even so, the sparse nature of the data limited 
them to two-dimensional solutions. In contrast, the Exploratory phase of the present analysis 
could sustain three-dimensional solutions because responses were pooled for each group. This 
in turn enabled us to observe differences in dimensional-salience parameters. 
The D-15 and D-15d tests of colour vision deficiency use colour samples that are spaced 
at roughly equal intervals around the hue circle and, within each test, do not vary in lightness or 
saturation. As normally administered, they do not probe the salience of lightness differences to 
a subject or test for saturation-dependent impairments. Combining the sample sets, as in the 
present study, introduces variations along these two achromatic characteristics (cf. Ref. 51). 
The results suggest that in the two clinical groups, the signal along the S0 or tritan system 
is greatly decreased for a stimulus containing a small component of blueness or yellowness, 
leaving the redness or greenness of the stimulus to dominate stimulus appearance and distorting 
its dissimilarities from other stimuli. Thus in the MDS solution, the desaturated stimuli collapse 
towards the R/G axis. Conversely, the dissimilarities perceived among the saturated stimuli are 
comparable to those for the controls, implying that sufficiently large blue or yellow components 
can still be detected and produce a normal S0 signal. 
A possible explanation is that mercury exposure and DM-2 impair the detection 
sensitivity of the S0 mechanism of colour vision. Blue-yellow sensitivity loss has indeed been 
reported in the case of mercury intoxication.
21,23
 The decreased S0 sensitivity is conceivably 
followed by a compensatory amplification along the blue-yellow system, but only if the original 
signal is large enough to rise above the threshold of noise.
16  
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Köllner’s rule states that an acquired blue-yellow deficiency can be traced to damage to 
the retina.
52
 Note though that mercury can affect the visual system in numerous ways, also 
impacting on the optic nerve and visual cortex.
26,27 
One cannot expect either of the clinical groups to be homogeneous, given the large 
variations in the factors contributing to their acquired colour vision deficiency, i.e. length and 
dosage of mercury exposure and the progressive nature of DM-2. Indeed, the MDS approach 
reveals considerable variation in the Hg-exposed and DM-2 groups: despite their tendency as 
groups toward lower wm2, some fell within the distribution of control observers and some 
departed from the controls in the opposite direction, towards insensitivity to red-green 
differences (Figures 2 and 3). Thus estimating the weights of colour-space axes is not on its 
own sufficient to unambiguously diagnose the stage of diabetes progression or the impact of 
mercury exposure. However, the tendency is a reminder of the importance of examining colour 
vision function when either condition is suspected. 
Several studies of mercury-exposed populations that used the Cambridge Colour Test to 
quantify chromatic discrimination thresholds directly along protan, deutan and tritan confusion 
lines
24,25,28,32
 all found a general, diffuse loss of sensitivity, rather than increased thresholds 
confined to a specific axis. Note though that in these studies the threshold measurements were 
averaged across subjects – who were affected to various degrees and may have suffered from 
different forms of colour vision deficiency. 
Clinical group subjects were tested twice, with left and right eye. The correlations 
between calculated left-eye and right-eye parameters are significant (at p = 0.003 or less): 0.391 
for wm2, 0.558 for wm3, and 0.566 for likelihood lm. Some of the differences may be real, since 
visual impairment from mercury exposure or diabetes need not affect both eyes with equal 
severity.
29
 However, the confidence bounds around these dimensional weights (Figure 4) 
indicate that 70 triads are not enough to confine their values very closely, reducing the test–
retest reliability of the MDS analysis. 
18 
 
The higher mean wm3 in the two clinical groups may indicate a form of compensation for 
less reliable chromatic discrimination, with these subjects placing more weight on lightness 
cues as a criterion for making odd-one-out judgements. The high correlation between wm3 for 
left-eye and right-eye observations suggests that the increase is central rather than peripheral in 
nature, e.g. binocular interaction and/or attentional factors. Notably, Stalmeier and de Weert, 
using the complete method of triads, found that the salience of lightness was modulated by 
selective attention.
53
 Increased weight of the lightness dimension was also found for 
congenitally colour abnormal observers.
49, 50,54 
This ‘compensatory’ explanation leaves open a second possibility: the fact is that wm3 is 
not measured in absolute terms, but only relative to the weight placed on the first, R/G 
dimension; hence any condition that impairs red-green discrimination without affecting 
lightness discrimination necessarily increases the relative weight of the latter. 
Finally, the significantly lower likelihoods lm for colour spaces of subjects in the clinical 
groups (Table 2) deserve further comment. Specifically, if the affected subjects viewed colour 
differences in the distorted way modelled here, i.e. decreased distances along the Blue-Yellow 
axis for desaturated stimuli, but made odd-one-out judgements that were reliable in those 
distorted terms, their lm values would be no lower than those of the controls. The observed low 
values of lm indicate that clinical group subjects were in fact responding less reliably, i.e. their 
colour discrimination was generally poorer. 
The present approach may be sensitive to conditions such as complex dyschromatopsia, 
which the conventional D-15d appears to underestimate.
55
 The analysis is equally applicable to 
data elicited with other tasks, for instance pairwise numerical scaling. The method of triads has 
advantages, though, including the relative simplicity of the judgments required of the subject,
56
 
and the simplicity of Maximum Likelihood estimation when the data take the form of 
dissimilarity comparisons.
46
 The use of randomized triads rather than a standardized list 
introduces some variation among subjects. Future research in this direction could use a 
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standard, pre-determined list of triads; for instance, a ‘balanced incomplete design’ with λ = 2 
where each pair of stimuli appears twice.
56 
We have noted that MLE provides an objective test for choosing between alternative 
explanatory models, the Likelihood Ratio test. This is suitable for comparing nested models 
where one model’s parameters are a subset of the other’s. Another test, the Akaike Information 
Criterion (AIC), is available for comparing Likelihood values between non-nested models.
46
 A 
further advantage of the MLE approach is the ease with which confidence bounds can be found 
around parameters when fitting models to individuals or groups to summarise their data. 
The resulting data can capture subtle but distinctive patterns of colour-vision impairment 
when analysed with individual-differences MDS. There are potential applications as a 
diagnostic tool – assuming that more triads are collected – and for monitoring the status of an 
acquired condition. A mixed stimulus set was used, with two values of lightness and saturation, 
because the dimensions of colour space spanned by the stimuli define the forms of impairment 
and compensation detectable in this way. A realistic model of individual difference is a second 
requirement. The model introduced here – that posits impaired discrimination restricted to 
unsaturated colours – is more in keeping with clinical reports than the usual weighted-
Euclidean model, and appears to be a better fit to the data. 
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Appendix: Maximum-Likelihood Estimation MDS 
When a subject chooses cap A as the odd-one-out of the triad {A,B,C}, this is tantamount to 
ranking the cap pair (B,C) as more similar than the two other pairs (A,B) and (A,C). Writing 
‘diss(A,B)’ for the subjective dissimilarity between A and B, this in turn can be considered as a 
pair of dissimilarity comparisons: diss(A,B) > diss(B,C), diss(A,C) > diss(B,C), at the time of 
the decision. It is convenient to express this in a shorthand form: AB » BC, AC » BC. 
MDS postulates that diss(A,B) can be modelled by the distance dAB in a low-dimensional 
space. Specifically, we assume without loss of generality that diss(A,B) = dAB + e(0), where 
e(0) is a random error term with a mean of 0. If the subject were infallible, so e(0) = 0, his or 
her choices would follow a step probability function of the difference between distances 
Δ(AB,BC) = dAB-dBC : 
                           1 if Δ(AB,BC) > 0 
 pr(AB » BC) =  0.5 if Δ(AB,BC) = 0 
 0 if Δ(AB,BC) < 0. 
In practice, of course, subjects are fallible – or rather, they are inconsistent, with the 
perception of any dissimilarity changing from one comparison to another – and although the 
probability approaches 0 or 1 if Δ(AB,BC) is sufficiently negative or positive, the transition 
between them is a smooth ogive. Following Thurstone’s Model of Pairwise Comparison, we 
assume that the error contributions are normal in form. Then pr(AB » BC | Δ(AB,BC)) = Φ(β 
Δ(AB,BC)), where the cumulative density function Φ(x) is the integral of the normal 
distribution and the parameter β is the observer’s ‘discriminance’, higher values denoting a 
more discerning, consistent set of judgements. 
The likelihood that a given combination of interpoint distances in a spatial model would 
have produced the observed list of dissimilarity comparisons from a given subject – or from a 
group of subjects being analysed together – is the product of all the corresponding probabilities. 
In the present case there are 140 comparisons per subject (two from each triad), ranking the 435 
dissimilarities among the 30 stimuli. Their product is a goodness-of-fit function, with 
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Maximum Likelihood Estimation working to maximise this combined likelihood by finding the 
optimum values of parameters. 
It is convenient to work with the logarithm of the likelihood, so as to replace the product 
with a sum of terms: 
LL = log likelihood = Σ log(Φ(β Δ(AB,BC))). 
A version of this, normalised over the subject’s 140 comparisons, is lm = exp(LL/140). 
For comparison, the older MDS programs MINITRI
57
 and TRISOSCAL
58
 employ a 
least-squares algorithm that defines and minimises a ‘badness-of-fit’ Stress function. Each 
comparison of the form AB » BC contributes a quadratic term (dAB-dBC)
2
 to Stress if dAB < dBC, 
or 0 if the model agrees with the data (dAB > dBC). It is worth noting that for sufficiently large 
discriminance β, the MLE and least-squares algorithms become equivalent (i.e. the former 
includes the latter as a special case), due to the nature of the log(Φ(x)) function, which becomes 
quadratic for large negative values of x while levelling off at 0 for large positive x. 
 In one of the present analyses, the parameters are the coordinates xip locating 30 points 
in three-dimensional space (1 i 30, 1 p 3), which can be written as a 30-by-3 matrix X. 
MTRIAD follows a hill-climbing strategy. The coordinates are optimised through a series of 
iterations X, X', X''..., in a process analogous to the two-dimensional case of climbing a hill, by 
finding the direction at each X' in which the slope is steepest (i.e. in which LL(X) increases 
most rapidly) and taking a step in that direction.  
 For this, the partial differential of Likelihood for each inter-point distance LL(X)/ dij is 
calculated: for every comparison in the data between that pair of stimuli and another pair, there 
is a contribution of the form log(Φ(β (dij-djk))) / dij. These differentials LL(X)/ dij are 
converted into partial differentials for each coordinate, LL(X)/ xip. The hill-climbing strategy 
is also common in least-squares implementations of MDS, though the individual contributions 
are simpler. Constraints among the coordinates are easily incorporated in this process. 
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Table legends 
 
Table 1. Variance of the coordinates along each dimension of colour space (as a fraction of total 
variance in that solution) for MDS solutions of the controls (XC), mercury-exposed 
subjects (XHg) and diabetes patients (XDM-2). 
 
Table 2. Means and standard errors for dimension-weight parameters wm2, wm3 and normalised 
likelihood-per comparison lm = exp(LL(Xm)/140) within each group, when X0 is adjusted 
to each subject’s responses (left-hand columns). Probability (t-value) of pairwise 
differences between the groups (right-hand columns). These dimensional parameters are 
not measured in absolute terms, only relative to wm1 = 1 for all observers. 
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Figure legends 
 
Figure 1. The three-dimensional MDS solutions for triadic data from controls (top), mercury 
(Hg)-exposed subjects (middle), and diabetes (DM-2) patients (bottom). Perspective 
views (left) and projections on the first two dimensions (right).  darker/saturated D-15 
caps;  lighter/desaturated D-15d caps. The labels of caps along the desaturated 
sequence in right-hand panels are omitted for the sake of clarity. 
 
Figure 2. Distributions of dimensional-weight parameters fitted to data from individual subjects 
in the three groups (controls, Hg-exposed and DM-2 patients): wm2, salience of 
differences along the Blue-Yellow dimension, D2 (top), and wm3, salience of differences 
along the lightness dimension, D3 (bottom). 
 
Figure 3. Scatterplot of dimensional-weight parameters wm2 and wm3 fitted to individual 
subjects’ data. Points colour-coded to distinguish controls, mercury (Hg)-exposed 
subjects and diabetes (DM-2) patients. 
 
Figure 4. Parameters wm2 and wm3 for seven representative subjects (two from Control, two 
from Hg and three from DM-2 groups, points coloured as in Figure 3), each surrounded 
by 95% and 99% confidence boundaries (darker and lighter ellipsoids). 
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Table 1 
 
 D1      D2    =       D2 (sat.)+D2 (desat.) D3 
XC 0.54 0.28 0.16 0.12 0.16 
XHg 0.48 0.22 0.14 0.08 0.29 
XDM-2 0.53 0.23 0.15 0.07 0.25 
 
 
 
 
 
 
 
 
 
 
Table 2 
 
 controls Hg DM-2 C : clinical C : Hg C : DM-2 
    131 d.f. 65 d.f. 87 d.f. 
  mean (SE)   p (t)  
wm2 1.08 (0.07) 0.91 (0.09) 0.76 (0.06) 0.004 (3.04) n.s. (1.52) 0.001 (3.53) 
wm3 1.02 (0.10) 1.56 (0.08) 1.41 (0.06) 0.000 (-4.39) 0.000 (-4.30) 0.000 (-3.80) 
 lm 0.734 (0.024) 0.644 (0.018) 0.623 (0.021) 0.003 (3.05) 0.005 (2.94) 0.005 (2.91) 
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